Sponsor:
L. Nicolas Gonzalez Castro, MD, PhD
Code:
NCT05463848
Conditions
Glioblastoma
Recurrent Glioblastoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Olaparib
Temozolomide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by L. Nicolas Gonzalez Castro, MD, PhD on 2025-02-06.